Publicacións nas que colabora con Luis Vicente Martínez Dolz (37)

2026

  1. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis

    Heart, Vol. 112, Núm. 4, pp. 223-230

2025

  1. Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry

    Biomedicines, Vol. 13, Núm. 5

  2. NT-proBNP in Acute De Novo Heart Failure: A Key Biomarker for Predicting Myocardial Recovery—COMFE Registry

    Life, Vol. 15, Núm. 4

2023

  1. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  2. Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients

    Transplantation, Vol. 107, Núm. 9, pp. 2064-2072

2022

  1. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147

  2. MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats

    Antioxidants, Vol. 11, Núm. 10

  3. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Ischemic etiology and prognosis in men and women with acute heart failure

    Journal of Clinical Medicine, Vol. 10, Núm. 8

2019

  1. Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection

    Scientific reports, Vol. 9, Núm. 1, pp. 13880

  2. The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy

    PLoS ONE, Vol. 14, Núm. 4

2018

  1. ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients

    ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737

  2. Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients

    European Journal of Heart Failure

  2. Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function

    PLoS ONE, Vol. 12, Núm. 9

  3. SERCA2a: A potential non-invasive biomarker of cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 36, Núm. 12, pp. 1322-1328

  4. Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study

    International Journal of Cardiology, Vol. 243, pp. 27-33

2016

  1. New altered non-fibrillar collagens in human dilated cardiomyopathy: Role in the remodeling process

    PLoS ONE, Vol. 11, Núm. 12

  2. TRPM7 is down-regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function

    ESC Heart Failure, Vol. 3, Núm. 3, pp. 220-224

2015

  1. ATP synthase subunit alpha and LV mass in ischaemic human hearts

    Journal of Cellular and Molecular Medicine, Vol. 19, Núm. 2, pp. 442-451